Curbstone Financial Management Corp Has $1.55 Million Stake in Colgate-Palmolive (NYSE:CL)

Curbstone Financial Management Corp raised its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 23.2% in the fourth quarter, Holdings Channel reports. The fund owned 16,990 shares of the company’s stock after acquiring an additional 3,200 shares during the period. Curbstone Financial Management Corp’s holdings in Colgate-Palmolive were worth $1,545,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Griffin Asset Management Inc. grew its stake in Colgate-Palmolive by 2.4% during the fourth quarter. Griffin Asset Management Inc. now owns 17,421 shares of the company’s stock worth $1,584,000 after buying an additional 405 shares during the last quarter. IRON Financial LLC grew its position in Colgate-Palmolive by 3.3% during the 4th quarter. IRON Financial LLC now owns 9,366 shares of the company’s stock worth $851,000 after acquiring an additional 299 shares during the last quarter. Nilsine Partners LLC increased its holdings in Colgate-Palmolive by 14.3% during the 4th quarter. Nilsine Partners LLC now owns 9,412 shares of the company’s stock valued at $856,000 after purchasing an additional 1,176 shares in the last quarter. Parsons Capital Management Inc. RI raised its position in Colgate-Palmolive by 1.0% in the 4th quarter. Parsons Capital Management Inc. RI now owns 15,521 shares of the company’s stock valued at $1,411,000 after purchasing an additional 154 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC grew its holdings in shares of Colgate-Palmolive by 5.5% during the fourth quarter. Mount Yale Investment Advisors LLC now owns 3,299 shares of the company’s stock worth $300,000 after purchasing an additional 173 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $91.19 on Tuesday. The stock has a fifty day simple moving average of $91.81 and a 200 day simple moving average of $97.45. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $74.50 billion, a price-to-earnings ratio of 26.13, a PEG ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.19%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. UBS Group decreased their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Finally, TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $101.11.

Read Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.